• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    iShares Russell 2000 BuyWrite ETF (NY:IWMW)

    39.77 -0.32 (-0.80%)
    Official Closing Price Updated: 8:00 PM EST, Jan 23, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about iShares Russell 2000 BuyWrite ETF

    < Previous 1 2 3 4 5 Next >
    News headline image
    Sable Offshore Plunged 14% Today – What Is The Feud With California State? ↗
    California Attorney General Rob Bonta on Friday filed a lawsuit against the Trump Administration, challenging the Pipeline and Hazardous Materials Safety Administration’s (PHMSA) orders of allowing... 
    Via Stocktwits
    Topics Government Lawsuit
    News headline image
    Why This Small-Cap Penny Stock Is Rallying Today – Traders Expect Stock Price To Double ↗
    United States Antimony earlier in the week announced the closing of a property acquisition of a critical minerals flotation facility. 
    Via Stocktwits
    News headline image
    ALT Stock Rallies 4% — What Does Retail Think? ↗
    Earlier this month, Altimmune said the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for pemvidutide for the treatment of patients with metabolic... 
    Via Stocktwits
    Bumble Chief Product Officer Reportedly Exits Amid Dating Platform’s ‘Return To Growth’ Efforts ↗
    Via Stocktwits
    News headline image
    BigBear.ai Shares Tumble 8% Ahead Of Crucial Shareholder Vote Deadline On Increasing Authorized Shares ↗
    The company wants its investors to approve an amendment for increasing its authorized common shares from 500 million to 1 billion shares. 
    Via Stocktwits
    Topics Artificial Intelligence
    VITL Shares Slip 6% On Health Concerns Around Eggs: Analyst Dismisses ‘Misleading’ Information, Reiterates ‘Buy’ Rating ↗
    Via Stocktwits
    USA Rare Earth Rallies More than 11% - What’s Driving The Optimism? ↗
    Via Stocktwits
    IBRX Stock Extends Rally On FDA Feedback For ANKTIVA Bladder Cancer Filing ↗
    Via Stocktwits
    News headline image
    CAPR Stock Slides After FDA Requests More Data For Genetic Disorder Therapy — What Does Retail Think? ↗
    The FDA has formally requested the full HOPE-3 clinical study report (CSR) and supporting data, Capricor said on Tuesday. 
    Via Stocktwits
    IBRX Stock Continues Rally — What’s Driving The Optimism Today? ↗
    Via Stocktwits
    News headline image
    TGTX Rallies 7% After Hours On Revenue Estimates Based On Strong Briumvi Demand Through 2026 ↗
    The company expects total revenue for full year 2025 to be about $616 million, including $594 million from sales of its Briumvi in the U.S. 
    Via Stocktwits
    Topics Artificial Intelligence
    Bakkt Stock Rallies Nearly 20% - What’s Behind The Move? ↗
    Via Stocktwits
    SELLAS Life Sciences Falls For Fourth Straight Session — What’s Driving The Sell Off? ↗
    Via Stocktwits
    RYTM Stock Jumps 4% On Imcivree Revenue Growth: Firm Awaits Approval In Acquired Hypothalamic Obesity By March ↗
    Via Stocktwits
    MannKind Rallies On Optimism Of Two Imminent Product Launches: Analyst Sees ‘Multiple Headwinds’ For Stock In 2026 ↗
    Via Stocktwits
    Rumble Rallies After Unveiling Tether-Powered Crypto Wallet – Retail Expects Stock To Surpass The $10 Mark ↗
    Via Stocktwits
    Zeta Global Shares Rose After It Deepens Collaboration with OpenAI ↗
    Via Stocktwits
    Rigetti Computing Stock Draws Retail Buzz After Quantum Timeline Slips And Insider Sale Surfaces ↗
    Via Stocktwits
    News headline image
    KalVista Pharmaceuticals Stock Rallies After Hours On Strong Genetic Disorder Drug Sales Kickstart ↗
    Ekterly is the first and only oral on-demand treatment for HAE, KalVista said, setting it apart from other on-demand HAE treatment options approved in the U.S. 
    Via Stocktwits
    News headline image
    Ardelyx Stock Is Rallying – What Is Making Retail So Bullish? ↗
    The company said it made significant commercial progress in 2025, generating approximately $378 million in product revenue. 
    Via Stocktwits
    News headline image
    ELVN Stock Shot Up 60% Today – What’s Driving The Rally? ↗
    The company reported positive initial data from its ongoing Phase 1b clinical trial evaluating ELVN-001 in patients with chronic myeloid leukemia. 
    Via Stocktwits
    News headline image
    Joby Inks $61.5 Million Deal To Acquire Another Ready-To-Use Facility In Ohio As It Eyes Doubling eVTOL Production ↗
    The new facility spans more than 700,000 feet and is ready for immediate use, the California-based company said. 
    Via Stocktwits
    News headline image
    WULF Stock Rises 3% Pre-Market After Keefe More Than Doubles Price Target ↗
    Keefe Bruyette upgraded TeraWulf to an ‘Outperform’ rating from ‘Market Perform’, citing its optimism on the company’s high-performance computing transition. 
    Via Stocktwits
    News headline image
    Verastem Oncology Stock Drops After Hours After Discontinuing A Clinical Trial In Lung Cancer ↗
    The company discontinued its trial in advanced KRAS G12C-mutated non-small cell lung cancer (NSCLC) following evaluation of interim data. 
    Via Stocktwits
    Topics Supply Chain
    News headline image
    SELLAS Life Sciences Group Stock Soars As It Nears Final Analysis In Cancer Study ↗
    The ongoing GPS trial is an overall survival study and final analysis is expected once 80 deaths have occurred. 
    Via Stocktwits
    Topics Death
    News headline image
    Tonix Pharmaceuticals To Meet With FDA In 2026 To Advance Experimental Lyme Disease Prevention Drug ↗
    The company also announced the pricing of a $20 million registered direct offering. 
    Via Stocktwits
    News headline image
    Why Is UUUU Stock Rising Today? ↗
    The company said that its finished uranium production, mined uranium ore production, and uranium concentrate sales for FY 2025 exceeded previously announced guidance. 
    Via Stocktwits
    Topics Government World Trade
    News headline image
    Biohaven Stock Slumps After Hours As Failed Depression Study Adds To A Brutal 2025 — Retail Eyes Epilepsy And Obesity Catalysts ↗
    The company said that no reduction in depressive symptoms were observed in the BHV-7000 trial over six weeks as compared with placebo. 
    Via Stocktwits
    News headline image
    Edgewise Therapeutics Stock Jumps After Trial Update For Genetic Heart Disease — Wall Street Eyes A Potential Standout ↗
    The investigational drug EDG-7500 was generally well tolerated in the trial, the company said. 
    Via Stocktwits
    News headline image
    SLS Stock Has Risen 78% In A Month — What’s The Retail Buzz About? ↗
    Retail investors are actively discussing recent clinical trials and the potential for a buyout or takeover. 
    Via Stocktwits
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.